<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION
OF REGISTRATION UNDER SECTION 12(g) OF THE
SECURITIES EXCHANGE ACT OF 1934
Commission File Number: 000-23076
SPARTA PHARMACEUTICALS, INC.
- --------------------------------------------------------------------------------
(Exact name of Registrant as specified in its charter)
111 Rock Road, Horsham, Pennsylvania 19044, (215) 442-1700
- --------------------------------------------------------------------------------
(Address, including zip code, and telephone number,
including area code, of Registrant's principal
executive offices)
Units, each consisting of one-fifth of one share of Common Stock, $.001 par
value per share, one redeemable Class A Warrant to purchase twenty-four
one-hundredths shares of Common Stock, $.001 par value per share, and one
redeemable Class B Warrant to purchase twenty-four one-hundredths shares of
Common Stock, $.001 par value per share
Redeemable Class A Warrants, each exercisable for the purchase of
twenty-four one-hundredths shares of Common Stock, $.001 par value per share
Redeemable Class B Warrants, each exercisable for the purchase of
twenty-four one-hundredths shares of Common Stock, $.001 par value per share
Redeemable Class C Warrants, each exercisable for the purchase of one share
of Common Stock, $.001 par value per share
Common Stock, $.001 par value per share
(Title of each class of securities covered by this form)
None
(Titles of all other classes for which
a duty to file reports under
Section 13(a) or 15(d) remains)
<PAGE>
Please place an X in the box(es) to designate the appropriate rule
provision(s) relied upon to terminate or suspend the duty to file reports:
Rule 12g-4(a)(1)(i) [X] Rule 12h-3(b)(1)(ii) [ ]
Rule 12g-4(a)(1)(ii) [ ] Rule 12h-3(b)(2)(i) [ ]
Rule 12g-4(a)(2)(i) [ ] Rule 12h-3(b)(2)(ii) [ ]
Rule 12g-4(a)(2)(ii) [ ] Rule 15d-6 [ ]
Rule 12h-3(b)(1)(i) [X]
Approximate number of holders of record as of the certification or notice
date: 1
On August 12, 1999, Royale Acquisition Corp., a wholly-owned subsidiary of
SuperGen, Inc. ("SuperGen"), was merged with and into Sparta Pharmaceuticals,
Inc. (the "Company"). The Company was the surviving corporation, and, upon
effectiveness of the merger, the Company became a wholly-owned subsidiary of
SuperGen.
Pursuant to the requirements of the Securities Exchange Act of 1934,
Sparta Pharmaceuticals, Inc. has caused this certification/notification to be
signed on its behalf by the undersigned duly authorized person:
SPARTA PHARMACEUTICALS, INC.
Date: August 12, 1999 By: /s/ DR. JOSEPH RUBINFELD
------------------------------
Dr. Joseph Rubinfeld
President
